Objective: To determine the diagnostic value of fractional exhaled nitric oxide (FeNO) measurement in diagnosis of Cough Variant Asthma (CVA) in children.
Methods: Outpatients with a cough > 4 weeks visiting The Children's Hospital Affiliated to Suzhou University from March 2012 to April 2013 were enrolled. FeNO was measured by a nitric oxide analyzer in accordance with American Thoracic Society guidelines. The levels of FeNO in CVA and other causes of chronic cough were compared. The value of FeNO was assessed and the optimal operating point of FeNO testing for the diagnosis of CVA was determined by the means of the receiver operating characteristic (ROC) curves.
Results: A total of 84 children with chronic cough were recruited, among whom 38 were diagnosed as having CVA. The levels of FeNO were not statistically different between patients with CVA [(37.2 ± 13.8) ppb] and patients with CVA combined with upper airway cough syndrome [UACS, (40.1 ± 13.8) ppb, P = 0.124], but were both significantly higher than those in patients with UACS or with postinfectious cough (PIC), and the normal control group (P < 0.01 respectively). There were 46 non-CVA patients, including 34 cases with UACS and 12 PIC, and their FeNO levels were not statistically different [(18.3 ± 7.6) to (19.2 ± 4.4) ppb, t = 2.580, P = 2.996]. The levels of FeNO declined rapidly in CVA patients after inhaled corticosteroids during the 4 week follow-up. The proportion of eosinophils in the sputum from CVA patients was higher than that from the non-CVA patients, consistent with the level of FeNO, which showed a positive linear correlation with sputum eosinophils. The area under ROC curve was 0.94.The optimal diagnostic cutoff point was 22.5 ppb which was capable of differentiating CVA and non-CVA with a sensitivity of 84%, and a specificity of 94.3%.
Conclusions: The level of FENO was higher in CVA compared to other causes of chronic cough. FeNO, a marker of airway eosinophilic inflammation, may be helpful in the diagnosis of CVA in children with high sensitivity and specificity.
Download full-text PDF |
Source |
---|
Plant Physiol Biochem
January 2025
Laboratory of Microbial Genetics, Department of Botany, Institute of Science, Banaras Hindu University, Varanasi, 221005, India. Electronic address:
Nitric oxide synthases (NOSs) are heme-based monooxygenases that catalyze the NADPH-dependent oxidation of L-arginine to produce NO and L-citrulline. Over the past five years, the identification and characterization of NOS homologs in cyanobacteria have significantly advanced our understanding of these enzymes. However, the precise mechanisms through which NOS-derived NO influences nitrogen metabolism remain incompletely elucidated.
View Article and Find Full Text PDFJ Neurosurg
January 2025
4Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Objective: The pathophysiology of delayed cerebral ischemia (DCI) is not fully elucidated. The lack of accurate diagnostic tools increases the probability of delayed diagnosis and timely treatment. The authors assessed the relationship of 8-iso-prostaglandin F2α (F2-IsoP) and oxidative stress biomarkers, nitric oxide synthase 3 (NOS3) and nicotinamide adenine dinucleotide phosphate (NADPH), with DCI after aneurysmal subarachnoid hemorrhage (aSAH).
View Article and Find Full Text PDFPLoS One
January 2025
Department of Clinical Science, SUS, Division of Islet Cell Physiology, University of Lund, Malmö, Sweden.
The impact of islet neuronal nitric oxide synthase (nNOS) on glucose-stimulated insulin secretion (GSIS) is less understood. We investigated this issue by performing simultaneous measurements of the activity of nNOS versus inducible NOS (iNOS) in GSIS using isolated murine islets. Additionally, the significance of extracellular NO on GSIS was studied.
View Article and Find Full Text PDFJ Mater Sci Mater Med
January 2025
Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland.
Macrophage metabolism is closely linked to their phenotype and function, which is why there is growing interest in studying the metabolic reprogramming of macrophages. Bioactive glass (BG) S53P4 is a bioactive material used especially in bone applications. Additionally, BG S53P4 has been shown to affect macrophages, but the mechanisms through which the possible immunomodulatory effects are conveyed remain unclear.
View Article and Find Full Text PDFParasitol Res
January 2025
Facultad de Química, Universidad Autónoma de Yucatán (UADY), Calle 43 S/N entre calle 96 y calle 40 Colonia Inalámbrica, Mérida, Yucatán, C.P. 97069, Mexico.
Chagas disease is a chronic infection caused by the protozoan parasite, Trypanosoma cruzi, with limited benefits of the currently available anti-parasitic chemotherapeutic approaches to halt the progression of heart disease. Recombinant TSA-1-C4 and Tc24-C4 proteins have been developed as promising antigen candidates for therapeutic vaccines, leading to propose them in combination as a bivalent recombinant protein strategy. In this study, we evaluated the immunomodulatory effect of the combined TSA-1-C4 and Tc24-C4 recombinant proteins by in vitro assays using murine macrophages.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!